Return to home page
Searching: Muskingum library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
     
Limit to items not checked out
Nearby SUBJECTS are:
   « Prev Next »
Save Marked Save All
    Year Entries
Drugs -- Therapeutic use. : Diseases, drugs, and quality of life / Marwan S.M. Al-Nimer.  2012 1
Drugs -- Therapeutic use -- United States.   3
Drugs -- Toxicity testing.   2
Drugs -- Toxicity testing -- Handbooks, manuals, etc. : Preclinical development handbook Toxicology / [edited by] Shayne Cox Gad.  2008 1
Drugs -- Toxicology.   19
Drugs -- Toxicology -- Handbooks, manuals, etc. : Preclinical development handbook Toxicology / [edited by] Shayne Cox Gad.  2008 1
Drugs -- Toxicology -- International cooperation. : Nonclinical safety assessment : a guide to international pharmaceutical regulations / edited by William J. Brock, Kenneth L. Hastings, and Kathy McGown.  2013 1
Drugs -- Toxicology -- Prevention -- Congresses. : Patient safety informatics : adverse drug events, human factors, and IT tools for patient medication safety / edited by Vassilis Koutkias [and others].  2011 1
Drugs -- Toxicology -- Risk assessment. : Benchmark dose technical guidance.  2012 1
Drugs -- Toxicology -- United States. : Pediatric nonclinical drug testing : principles, requirements, and practices / edited by Alan M. Hoberman, Elise M. Lewis.  2012 1
Drugs -- Treatment. : Reducing and preventing adverse drug events to decrease hospital costs.  2001 1
Drugs -- United States.   8
Drugs -- United States -- Analysis -- Government policy.   2
Drugs -- United States -- Bibliography. : Findings of drug abuse research : an annotated bibliography of NIMH and NIDA-supported extramural grant research 1967-74 in two volumes.  1975 1
Drugs -- United States -- Classification. : Accuracy of drug categorizations for Medicaid rebates.  2009 1
Drugs -- United States -- Classification -- Handbooks, manuals, etc. : Drug registration and listing instructions / Center for Drug Evaluation and Research, FDA.  1998 1
Drugs -- United States -- Cost control.   6
Drugs -- United States -- Costs.   12
Drugs -- United States -- Costs -- Government policy. : Medicaid outpatient prescription drugs : estimated 2007 federal upper limits for reimbursement compared with retail pharmacy acquisition costs.  2006 1
Drugs -- United States -- Costs -- Statistics. : Trends in prescribed medicine use and spending by older Americans, 1992-2001 / by Margie R. Goulding.  2005 1
Drugs -- United States -- Design.   4
Drugs -- United States -- Design -- Congresses.   2
Drugs -- United States -- Design -- Data processing. : Medications development : drug discovery, databases, and computer-aided drug design / editors: Rao S. Rapaka, Richard L. Hawks.  1993 1
Drugs -- United States -- Design -- Research. : Emerging technologies and new directions in drug abuse research / editors: Rao S. Rapaka, Alexandros Makriyannis, Michael J. Kuhar.  1991 1
Drugs -- United States -- Finance.   5
Drugs -- United States -- Finance -- Government policy.   4
Drugs -- United States -- Generic substitution.   6
Drugs -- United States -- Generic substitution -- Patents. : The generic challenge : understanding patents, FDA and pharmaceutical life-cycle management / Martin A. Voet.  2016 1
Drugs -- United States -- History. : Medicating modern America : prescription drugs in history / edited by Andrea Tone and Elizabeth Siegel Watkins.  2007 1
Drugs -- United States -- Marketing.   9
Drugs -- United States -- Marketing -- Corrupt practices.   3
Drugs -- United States -- Marketing -- Corrupt practices -- Prevention. : Drug Quality and Security Act http://id.loc.gov/authorities/names/no2013142536  2013 1
Drugs -- United States -- Marketing -- Government policy. : Guidance for FDA staff and industry : marketed unapproved drugs, compliance policy guide.  2006 1
Drugs -- United States -- Measurement. : Unit of measure Inconsistencies in the Medicaid prescription drug program.  2007 1
Drugs -- United States -- Patents.   8
Drugs -- United States -- Procurement -- Evaluation. : Review of services provided by inhalation drug suppliers.  2005 1
Drugs -- United States -- Quality control -- Government policy. : Guidance for industry : M4Q, the CTD, quality.  2001 1
Drugs -- United States -- Regulations -- Congresses. : Strengthening a workforce for innovative regulatory science in therapeutics development : workshop summary / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.  2012 1
Drugs -- United States -- Safety measures.   12
Drugs -- United States -- Safety measures -- Congresses.   2
Drugs -- United States -- Safety measures -- Econometric models. : Banning foreign pharmacies from sponsored search : the online consumer response / Matthew Chesnes, Weijia (Daisy) Dai, Ginger Zhe Jin.  2014 1
Drugs -- United States -- Safety measures -- Evaluation. : FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety.  2013 1
Drugs -- United States -- Safety measures -- Government policy.   8
Drugs -- United States -- Safety measures -- Research. : Mission possible : how FDA can move at the speed of science / report of the Science Looking Forward Subcommittee ; prepared for the FDA Science Board.  2015 1
Drugs -- United States -- States -- Costs.   2
Drugs -- United States -- Statistics.   3
Drugs -- United States -- Testing.   24
Drugs -- United States -- Testing -- Congresses.   2
Drugs -- United States -- Testing -- Documentation. : Guidance for industry : analytical procedures and methods validation, chemistry, manufacturing, and controls documentation.  2000 1
Drugs -- United States -- Testing -- Government policy.   11
Save Marked Save All
   « Prev Next »

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team